Stromatt Scott C

CIK 00016799751 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001679975

Recent Transactions

30 trades

Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2019-03-01−16,269→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2019-03-01+16,269→ 221,006 total
Tax Payment
Aptevo Therapeutics Inc.$APVO
Common Stock
2019-03-01$1.57/sh−4,823→ 216,183 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2019-02-28+67,400→ 67,400 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2018-03-09−13,892→ 16,269 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2018-03-09+13,892→ 204,737 total
Award
Aptevo Therapeutics Inc.$APVO
Employee Stock Options (Right to Buy)
2018-03-09+67,400→ 67,400 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2018-03-01+16,269→ 190,845 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2018-03-01−16,269→ 30,161 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2018-02-03+27,381→ 174,576 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2018-02-03−27,381→ 46,430 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2017-08-01+78,123→ 147,195 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2017-08-01−78,123→ 73,811 total
Award
Aptevo Therapeutics Inc.$APVO
Employee Stock Option (right to buy)
2017-06-01+33,700→ 33,700 total
Tax Payment
Aptevo Therapeutics Inc.$APVO
Common Stock
2017-03-10$1.78/sh−6,570→ 69,072 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2017-03-10−24,836→ 151,934 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2017-03-10+24,836→ 75,642 total
Tax Payment
Aptevo Therapeutics Inc.$APVO
Common Stock
2017-03-09$1.80/sh−3,678→ 50,806 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2017-03-09−13,902→ 176,770 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2017-03-09+13,902→ 54,484 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2017-03-01−16,269→ 190,672 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2017-03-01+16,269→ 45,894 total
Tax Payment
Aptevo Therapeutics Inc.$APVO
Common Stock
2017-03-01$2.02/sh−5,312→ 40,582 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2017-02-24+33,700→ 236,580 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2017-02-03+27,381→ 29,625 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2017-02-03−27,381→ 206,941 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2016-08-03+54,762→ 54,762 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2016-08-03+78,123→ 234,322 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2016-08-03+54,762→ 54,762 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2016-08-03+78,124→ 78,124 total

Companies

Aptevo Therapeutics Inc.
Chief Medical Officer and SVP
$APVO

Recent Filings

Address

2401 4TH AVENUE, SUITE 1050

SEATTLE, WA, 98121

View on SEC.gov